Advisory Group recommendations on priorities for the IARC Monographs

Lancet Oncol. 2024 May;25(5):546-548. doi: 10.1016/S1470-2045(24)00208-0. Epub 2024 Apr 12.

Authors

Amy Berrington de González¹, Scott A Masten¹, Parveen Bhatti¹, Renée Turzanski Fortner¹, Susan Peters¹, Tiina Santonen¹, Marianna G Yakubovskaya¹, Robert Barouki¹, Silvia B M Barros¹, Dinesh Barupal¹, Laura E Beane Freeman¹, Gloria M Calaf¹, Joakim Dillner¹, Karima El Rhazi¹, Lin Fritschi¹, Shoji Fukushima¹, Lode Godderis¹, Manolis Kogevinas¹, Dirk W Lachenmeier¹, Daniele Mandrioli¹, Mazvita M Muchengeti¹, Richard T Niemeier¹, Jane J Pappas¹, Jingbo Pi¹, Mark P Purdue¹, Elio Riboli¹, Teresa Rodríguez¹, Vivi Schlünssen¹, Lamia Benbrahim-Tallaa¹, Aline de Conti¹, Caterina Facchin¹, Elisa Pasqual¹, Roland Wedekind¹, Ayat Ahmadi¹, Shirisha Chittiboyina¹, Zdenko Herceg¹, Shalini Kulasingam¹, Béatrice Lauby-Secretan¹, Richard MacLehose¹, Moez Sanaa¹, Joachim Schüz¹, Eero Suonio¹, Jiri Zavadil¹, Heidi Mattock¹, Federica Madia¹, Mary K Schubauer-Berigan¹

Affiliation

¹ International Agency for Research on Cancer, Lyon, France.

PMID: 38621402
DOI: 10.1016/S1470-2045(24)00208-0

No abstract available

MeSH terms

Advisory Committees
Health Priorities
Humans
Neoplasms* / therapy

Grants and funding